Exicure

Exicure 是一家在股票代码 XCUR (US) 下上市的公司。

查看带有其 6 名主要高管的组织结构图

Exicure 搜索最多的简介

• Paul Kang, Director and Chief Executive Officer
• Hyuk Joon Ko, Director
• Hojoon Lee, Director

创建提醒
跟踪 Exicure 的高管变动

Exicure 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。

Popular M&A news in 生物技术

• Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
• Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
• TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).

生物技术 行业的其他推荐联系人

• Scholar Rock 企业 Kristina Burow - Director
• UroGen 企业 Fred Cohen - Director
• Adaptimmune Therapeutics 企业 Ali Behbahani - Non-Executive Director

了解更多有关生物技术行业的信息 >

Exicure 的最新新闻稿

• Exicure, Inc. Receives Extension from Nasdaq Hearings Panel
• Exicure, Inc. Announces Proposed Settlement of Securities Class Action Litigation
• Exicure, Inc. Announces 1-for-5 Reverse Stock Split
• Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting
• Exicure, Inc. Reports Second Quarter 2024 Financial Results
• Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting
• Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics
• Exicure, Inc. Receives Positive Listing Determination from Nasdaq
• Exicure, Inc. Reports Full Year 2023 Financial Results
• Exicure, Inc. Received Nasdaq Notice of a Delisting Determination
• View more press releases Close

关于 Exicure 的社交媒体

• Exicure 在 维基百科、谷歌新闻 和 雅虎财经
• Exicure 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Paul Kang

致电Exicure，电话：+1 847...

查看组织结构图

Register to receive your alert

报告错误